150 | + | patients treated |
TO LEARN MORE ABOUT FARAWAVE AF ABLATION
FARAPULSE
PULSED FIELD ABLATION
FARAPULSE PFA is fundamentally different from thermal modalities such as radiofrequency and cryoablation.
Through the precise and momentary creation of a therapeutic electric field, FARAPULSE PFA treats uniquely-sensitive myocardium. Collateral, non-target tissues are spared due to their higher threshold to PFA.
FARAPULSE UPDATES
Data from HRS 2020
News Releases
Highlighted PFA Publications
Recorded PerAF Case Presentation
PFA Interview at VT Symposium 2019
FDA Breakthrough Designation
PRODUCTS
FARAPULSE is advancing tissue-selective PFA therapy on catheter and surgical platforms for both endocardial and epicardial approaches.

ENDO
FARAWAVE is an over-the-wire catheter designed to create durable and circumferential PFA lesions from a femoral approach. The variable morphology of FARAWAVE’s distal end is designed to treat a range of anatomies.

ENDO
FARAFLEX is a deflectable catheter designed to facilitate focal placement of PFA therapy and accommodate multiple strategies including linear ablation.

ENDO
FARAPOINT (in development) enables ultra-precise, focal delivery of FARAPULSE PFA on a familiar linear and deflectable catheter platform.

EPI
FARAONE is designed to create a circumferential lesion around the pulmonary veins and posterior left atrium. The catheter is surgically placed for an epicardial approach that does not require cardiopulmonary bypass.

Purpose-built, high-precision waveform generator designed to deliver tailored PFA therapy through all FARAPULSE catheters.
PEOPLE

Charles Eggert

Joan Simon

Allan Zingeler

Raju Viswanathan

Mark Wisniewski

Richard S. Brose

John Madden

Nayirie Tashjian

Bob Fowler

Jaya Kothule

Kit Schneider

Jacob Ruprecht

Blake Morrow

Eric Buck

Rosa Barriga

Lucas Suchomel

Mike Paré

Anitha Achyutha

Richard Kimura

John Lehmann

Anusha Chinthapally

Bin Chen

Ethan Berry

Diane Phillips

John Allison

Ricardo Aboytes

Gil Laroya

Ralf Blimke

Michael Wiley

Hien Lam

Janet O'Connor

George Mavroudis

Gary Long

Nainesh Sureja

Shruthi Chandran

Jeff ten Haken

Pragnesh Patel

Andrew Edgett

Muriel Bouchet

Samantha Jerrell
BOARD OF DIRECTORS
Mary Byron
Boston Scientific Ventures
James Eadie, MD
Santé Ventures
Andrew ElBardisi, MD
Deerfield Management
Robert Weisskoff, Ph.D.
F-Prime Capital
Allan Zingeler
President and CEO, FARAPULSE
NEWS/CONTACT
NEWS RELEASES
GENERAL INFORMATION
PHONE
650.422.3633
OFFICE
3715 Haven Ave, Suite 110
Menlo Park, CA 94025